Ms
Roxna
Kapadia

Patent Director

London Office

Life sciences

Telephone. +44 20 7776 5100
Email. [email protected]
Vcard
Linkedin

Experience

Roxna is a UK and European qualified patent attorney with in-depth knowledge and experience with viral cancer therapeutics, antibodies, stem cells, immunotherapy, genetics and food science. Roxna has in-house patent experience working at the small biotechnology company Oncolytics Biotech Inc. and at the multinational company General Electric Healthcare and Merck Sharp & Dohme.

Roxna has experience working before the EPO, UKIPO and WIPO, including drafting and filing applications, prosecution and EPO oppositions and appeals. Roxna also has extensive experience with IP due diligence, validity opinions and FTO analysis. Having worked both in house and in private practice, Roxna is well placed to provide business focused strategic intellectual property advice to her clients.

Roxna is a named inventor on a patent for a method of purifying viruses using gel permeation chromatography. Roxna developed and ran industry-focused intellectual property courses in London UK. In particular Roxna has taught Freedom to Operate courses for the Life Sciences and Pharmaceutical Industry.

Having grown up in Canada and worked in Switzerland, Roxna is fluent in English and French.

Specialisms

Industries

Services

Qualifications

Patent Attorney

Chartered (UK)
European

BSC

Microbiology and Immunology

MSC

Immunology

MSC

Management of Intellectual Property

Related News

Food technology companies and investors - the value of IP landscape analysis

Case study – alt fat innovation Many companies and investors are aware of the importance of identifying and protecting their innovations, and in particular of the importance of obtaining patents …

Read article
Event - 29th September 2022

North East Automotive Expo 2022

HGF will be exhibiting at The North East Automotive Alliance’s flagship Expo on 29th September 2022. The event is an industry highlight for companies operating within the region’s automotive supply …

Event details
Event - 21st-22nd September 2022

Medical Technology Ireland 2022

Medical Technology Ireland Conference 2022 will be held on 21-22 September at the Galway Racecource. Medical Technology Ireland is a new high-profile National and International event attracting global suppliers to …

Event details

Artificial intelligence inventions in healthcare – can you patent them in Europe?

Artificial Intelligence (AI) has moved from the realm of science fiction firmly into the mainstream of technological innovation. Trained AI models in some cases are able to perform data analysis …

Read article

Patenting digital mental health

Mental health and behavioural disorders have a profound impact on wellbeing worldwide, with an estimated 13% of the global population suffering from a mental health or substance use disorder [1]. …

Read article

Patenting antibodies in the US and Europe

Is the USPTO now stricter than the EPO on antibody claims? A consideration of recent developments from both sides of the pond. Patent protection for monoclonal antibodies, bispecific antibodies and …

Read article

Patentability of Simulations in Europe

Simulations offer a powerful tool in modern-day engineering. Subjecting designs to initial testing in a simulated environment will, for many designs, reduce costs owing to reduced needs to produce and …

Read article

Blockbuster blood thinning patent revoked

Summary Mr Justice Meade has revoked Bristol Myers Squibb’s (BMS) European patent No. EP1427415 (EP’415) and corresponding supplementary protection certificate (SPC) that relate to the compound Apixaban (ELIQUIS) for lack …

Read article
See all updates

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.

Contact us